Celerion, a leader in early clinical research services and clinical bioanalysis industry, is a global company with over 40 years of experience. Our unique combination of medical expertise, clinical operations experience and scientific excellence provides our customers with the confidence to make fast, accurate decisions about their drug development path within the clinical research process. Our state-of-the-art laboratories focus on science, compliance and speed to deliver high-quality data analysis. We apply our experience to exceed your expectations and use our resources to help get your product into the world faster, so you can start making a difference in people’s lives.
Biomarker and Bioanalytical Assays for Immuno-oncology Drug Development
Biomarkers in a regulated environment for immunotherapy drug development studies is crucial for understanding the mechanism of action of new drugs, profiling immune response and efficacy to therapy. When used for statistical comparisons the quality of the bioanalytical assay for a biomarker has a direct impact on the number of participants needed for the study. Celerion develops and validates the right assay for the biomarker, decreasing the timelines and cost of the clinical program.
Read more on 'Biomarker and Bioanalytical Assays for Immuno-oncology Drug Development' here